JRJC yields 50.13% · ABBV yields 3.06%● Live data
📍 JRJC pulled ahead of the other in Year 1
Combined, JRJC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JRJC + ABBV for your $10,000?
China Finance Online Co. Limited, together with its subsidiaries, provides web-based financial services in the People's Republic of China and Hong Kong. The company operates through two segments: Hong Kong Brokerage Services and Financial Services. It provides online access to securities trading services, wealth management products, and securities investment advisory services to retail investors; and financial database and analytics to institutional investors, including financial, research, academic, and regulatory institutions, as well as financial software products. The company is also involved in the operation of Yinglibao, an internet-based financial platform that integrates cash management solutions and mutual fund distribution into iTougu, which facilitates communication between securities investment advisors and their clients; JRJ mobile app for financial information, securities trading, investment advisory, and wealth management; jrj.com.cn to provide access for wealth management solutions and mutual fund distribution; jrj.com, a financial information website; and iTAMP, a turnkey asset management platform that offers investment consultations and advice covering stocks, mutual funds, wealth management, insurance, trusts, and other financial products. In addition, it provides securities and futures contracts brokerage and related services to its customers, who invest in stocks listed on The Stock Exchange of Hong Kong Limited; subscription to financial analysis tools, real-time and historical data, news, research reports, and online forums; asset management and insurance brokerage services; and advertising and enterprise value-added services, as well as online P2P lending and money lending services. China Finance Online Co. Limited has a strategic partnership agreement with Citic Securities to provide internet financial services. The company was incorporated in 1998 and is based in Beijing, the People's Republic of China.
Full JRJC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.